November 10th 2021
AS ONE CORPORATION
President:Takaji Iuchi
Security Code:7476
Contact:Keisuke Nishikawa Director
TEL: +81-6-6447-1210
October Sales by Sector for FYE March 2022
1.Net Sales trends | Millions of yen | |||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | |||||||||
FY03/2022 | 6,493 | 5,860 | 6,753 | 6,380 | 6,168 | 6,691 | ||||||||
FY03/2021 | 5,808 | 4,700 | 5,618 | 5,758 | 5,233 | 6,304 | ||||||||
FY03/2022 | +11.8% | +24.7% | +20.2% | +10.8% | +17.9% | +6.1% | ||||||||
% YoY | ||||||||||||||
Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | |||||||||
FY03/2022 | 6,581 | |||||||||||||
FY03/2021 | 6,794 | 6,432 | 7,306 | 7,191 | 7,615 | 8,971 | ||||||||
FY03/2022 | (3.1)% | |||||||||||||
% YoY | ||||||||||||||
2.Business day | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | |||
FY03/2022 | 21 | 18 | 22 | 20 | 19 | 20 | 21 | |||||||
YoY | ± 0 | ± 0 | ± 0 | ( 1) | + 1 | ± 0 | ( 1) | |||||||
Sales per day | +11.8% | +24.7% | +20.2% | +16.3% | +11.7% | +6.1% | +1.5% | |||||||
% YoY* | ||||||||||||||
*Since sales of consumables used in research, industry, and medical settings are linked to changes in the number of business days, we also place importance on daily sales.
3.Reference
Since sales in the current fiscal year will reactionary fall in the special demand due to corona crisis in the previous fiscal year, we indicate the comparison of 3/2020 before corona.
Apr. | May | Jun. | Jul. | Aug. | Sep. | |
+31.4% | +19.4% | +36.5% | +14.6% | +32.9% | +17.0% | |
Vs. 3/2020 | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. |
+27.5% |
About this material
The figures in these materials are non-consolidated figures that contain some provisional numbers from early reporting. They are provided to show trends for the convenience of investors. Temporarily uncategorized net sales, and adjustments for intra-Group transactions and deductions in consolidated financials are not accounted for. For purposes of reference, in fiscal year ended March 2021, the total annual net sales under this method were 77,729 million yen, annual net sales on a non-consolidated basis were 78,839 million yen, and consolidated net sales were 81,606 million yen.
1/4
Millions of yen・% | |||||||||||||||||||||
Scientific sector | |||||||||||||||||||||
5,000 | +80.0% | ||||||||||||||||||||
FY03/2021 | FY03/2022 | FY03/2021 | FY03/2022 | ||||||||||||||||||
% YoY | % YoY | ||||||||||||||||||||
4,500 | +70.0% | ||||||||||||||||||||
4,000 | +60.0% | ||||||||||||||||||||
3,500 | +50.0% | ||||||||||||||||||||
+41.8% | |||||||||||||||||||||
3,000 | +40.0% | ||||||||||||||||||||
2,500 | +30.0% | ||||||||||||||||||||
+26.1% | |||||||||||||||||||||
+20.2% | |||||||||||||||||||||
2,000 | +19.7% | +20.0% | |||||||||||||||||||
+16.9% | |||||||||||||||||||||
+16.2% | |||||||||||||||||||||
+12.8% | +14.9% | +14.1% | |||||||||||||||||||
+15.0% | +12.5% | ||||||||||||||||||||
+11.2% | +11.0% | ||||||||||||||||||||
+13.5% | +10.1% | ||||||||||||||||||||
1,500 | +7.3% | +10.0% |
+5.1%
+3.3%
1,000 | +0.0% | ||||||||||||||
500 | (10.0)% | ||||||||||||||
(16.0)% | |||||||||||||||
0 | (20.0)% | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
FY03/2020 | 2,594 | 2,683 | 2,785 | 3,081 | 2,548 | 3,187 | 2,889 | 2,918 | 3,178 | 3,391 | 3,771 | 4,375 | |||
FY03/2021 | 2,982 | 2,254 | 3,142 | 3,184 | 2,892 | 3,508 | 3,642 | 3,410 | 3,821 | 3,870 | 4,193 | 4,857 | |||
FY03/2022 | 3,465 | 3,197 | 3,762 | 3,584 | 3,324 | 3,764 | 3,827 | ||||||||
FY03/2021 | +15.0% | (16.0)% | +12.8% | +3.3% | +13.5% | +10.1% | +26.1% | +16.9% | +20.2% | +14.1% | +11.2% | +11.0% | |||
% YoY | |||||||||||||||
FY03/2022 | +16.2% | +41.8% | +19.7% | +12.5% | +14.9% | +7.3% | +5.1% | ||||||||
% YoY | |||||||||||||||
2/4
Millions of yen・% | |||||||
Industrial sector | |||||||
4,000 | +60.0% | ||||||
FY03/2021 | FY03/2022 | FY03/2021 | FY03/2022 | ||||
% YoY | % YoY | ||||||
3,500 | +50.0% | ||||||
3,000 | +40.0% | |
2,500 | +28.4% | +30.0% | |||
+21.7% | |||||
+19.8% | +19.8% | ||||
2,000 | +18.7% | +20.0% | |||
1,500 | +8.9% | +9.1% | +10.0% | |||
+7.5% | ||||||
+6.0% | +6.0% | +4.0% | +3.7% | |||
+1.0% | +4.2% | +2.5% | ||||
1,000 | (0.9)% | +0.0% | ||||
(8.0)% | ||||||
500 | (10.0)% | |||||
(12.1)%
(13.9)%
0 | (20.0)% | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
FY03/2020 | 1,187 | 1,179 | 1,177 | 1,360 | 1,104 | 1,289 | 1,244 | 1,248 | 1,204 | 1,284 | 1,374 | 1,564 | |||
FY03/2021 | 1,277 | 1,037 | 1,189 | 1,171 | 1,015 | 1,278 | 1,355 | 1,301 | 1,429 | 1,332 | 1,409 | 1,706 | |||
FY03/2022 | 1,354 | 1,242 | 1,446 | 1,403 | 1,304 | 1,355 | 1,410 | ||||||||
FY03/2021 | +7.5% | (12.1)% | +1.0% | (13.9)% | (8.0)% | (0.9)% | +8.9% | +4.2% | +18.7% | +3.7% | +2.5% | +9.1% | |||
% YoY | |||||||||||||||
FY03/2022 | +6.0% | +19.8% | +21.7% | +19.8% | +28.4% | +6.0% | +4.0% | ||||||||
% YoY | |||||||||||||||
3/4
Millions of yen・% | ||||||||||
Hospital and Nursing | ||||||||||
4,000 | Care Sector | +96.0% | ||||||||
FY03/2021 | FY03/2022 | FY03/2021 | FY03/2022 | +90.9% | ||||||
% YoY | % YoY | +83.8% | ||||||||
3,500 | +80.0% | |||||||||
+75.1% | +76.4% | |||||||||
3,000+64.0%
+53.4% | |||||||
2,500 | +48.0% | ||||||
+34.9% | +34.1% | ||||||
+33.6% | +33.2% | ||||||
2,000 | +30.4% | +32.0% | |||||
+24.5% | |||||||
+20.0% | +22.3% | ||||||
1,500 | +16.2% | +16.0% | |||||
+8.1% | |||||||
+0.8% | +3.6% | ||||||
(0.7)% | |||||||
1,000 | +0.0% | ||||||
500 | (16.0)% | ||||||||||||||
(25.2)% | |||||||||||||||
0 | (32.0)% | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
FY03/2020 | 1,187 | 1,179 | 1,177 | 1,360 | 1,104 | 1,289 | 1,244 | 1,248 | 1,204 | 1,284 | 1,374 | 1,564 | |||
FY03/2021 | 1,549 | 1,410 | 1,287 | 1,403 | 1,326 | 1,518 | 1,797 | 1,721 | 2,057 | 1,989 | 2,013 | 2,407 | |||
FY03/2022 | 1,674 | 1,421 | 1,544 | 1,393 | 1,540 | 1,572 | 1,344 | ||||||||
FY03/2021 | +33.6% | +34.9% | +30.4% | +24.5% | +34.1% | +22.3% | +75.1% | +76.4% | +90.9% | +83.8% | +53.4% | +33.2% | |||
% YoY | |||||||||||||||
FY03/2022 | +8.1% | +0.8% | +20.0% | (0.7)% | +16.2% | +3.6% | (25.2)% | ||||||||
% YoY | |||||||||||||||
The previous fiscal year was a period of rapid growth due to | |||||||||||||||
the combination of high demand for medical supplies and the | |||||||||||||||
reactionary increase after the consumption tax hike. |
4/4
Attachments
- Original document
- Permalink
Disclaimer
As One Corporation published this content on 10 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2021 08:24:02 UTC.